RecruitingNCT06178744

A Study of AI in Cardiac Transplant in Echocardiographic Analysis (ORACLE)

Outcome Reflection for Immune Mediated Rejection by Utilizing Artificial Intelligence in Cardiac Transplant Patients Through Early and Late Echocardiographic Analysis (ORACLE)


Sponsor

Mayo Clinic

Enrollment

500 participants

Start Date

Apr 4, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this research is to detect episodes of rejection versus non-rejection after cardiac transplant and the diagnostic accuracy of an Artificial Intelligence (AI) algorithm using the data from an ECG (electrocardiogram) and Cardiac Ultrasound (Echocardiogram and/or point of care ultrasound).


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Patients undergoing post-cardiac transplant endomyocardial biopsy, and the ability to provide informed consent and a consent for the study.

Exclusion Criteria1

  • Refusal of study participation

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06178744


Related Trials